High-quality evidence in oncology from 16 June to 18 August 2005: A summary (original) (raw)

High-quality evidence in oncology from 25 August to 27 October 2005: A summary

Ben Djulbegovic

Cancer Treatment Rev, 2006

View PDFchevron_right

High-quality evidence in oncology from 14 April to 12 May 2005: A summary

Ben Djulbegovic

Cancer Treatment Reviews, 2005

View PDFchevron_right

High-quality evidence in oncology from 1 December to 22 December 2005: a summary

Ben Djulbegovic

Cancer Treatment Rev, 2006

View PDFchevron_right

Oncology treatment recommendations can be supported only by 1–2% of high-quality published evidence

Ben Djulbegovic

Cancer Treatment Reviews, 2005

View PDFchevron_right

High-quality evidence in oncology from 1st September to 14th October 2004: a summary

Ben Djulbegovic

Cancer Treatment Rev, 2005

View PDFchevron_right

High-quality evidence in oncology from 20th April to 11th May 2004: a summary

Ben Djulbegovic

Cancer Treatment Reviews, 2004

View PDFchevron_right

High-quality evidence in oncology from 22nd June to 26th August 2004: a summary

Ben Djulbegovic

Cancer Treatment Rev, 2005

View PDFchevron_right

High-quality evidence in oncology from 19 May to 9 June 2005: A summary

Ben Djulbegovic

Cancer Treatment Reviews, 2005

View PDFchevron_right

High-quality evidence in oncology from 18th May to 15th June 2004: a summary

Ben Djulbegovic

Cancer Treatment Reviews, 2004

View PDFchevron_right

Guidelines and questionnaire for reviewers - Archive of Oncology

Gordana Bogdanovic

Archive of oncology, 2002

View PDFchevron_right

High-quality evidence in oncology from 3 November to 24 November, 2005: A summary

Benjamin Djulbegovic

Cancer Treatment Reviews, 2006

View PDFchevron_right

Assessing the quality of randomized controlled trials from two leading cancer journals using the CONSORT statement

OMER UYSAL

Hematology/Oncology and Stem Cell Therapy, 2008

View PDFchevron_right

Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review

aurelie Bourmaud

PLOS ONE, 2017

View PDFchevron_right

Quality of systematic reviews used in guidelines for oncology practice

Federica Vigna-taglianti

Annals of Oncology, 2006

View PDFchevron_right

Treatment Success in Cancer<subtitle>New Cancer Treatment Successes Identified in Phase 3 Randomized Controlled Trials Conducted by the National Cancer Institute–Sponsored Cooperative Oncology Groups, 1955 to 2006</subtitle&gt

Benjamin Djulbegovic

Archives of internal medicine, 2008

View PDFchevron_right

Treatment-related harms: What was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a systematic review

Branko Miladinovic

Journal of Clinical Epidemiology, 2014

View PDFchevron_right

Treatment Success in CancerNew Cancer Treatment Successes Identified in Phase 3 Randomized Controlled Trials Conducted by the National Cancer Institute–Sponsored Cooperative Oncology Groups, 1955 to 2006

Iztok Hozo

Archives of Internal Medicine, 2008

View PDFchevron_right

Point-Counterpoint: Using Clinical Trials for the Evaluation of Integrative Cancer Therapies

Keith Block

Integrative Cancer Therapies, 2004

View PDFchevron_right

Relevance of randomised controlled trials in oncology

Saroj Niraula

The Lancet Oncology, 2016

View PDFchevron_right